Patents by Inventor Jangjoon PARK

Jangjoon PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING PAIN
    Publication number: 20220362342
    Abstract: A composition useful for alleviating or treating pain and uses thereof are disclosed. The composition containing glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine. A method for alleviating or treating pain of a subject includes administering the composition to the subject.
    Type: Application
    Filed: July 28, 2022
    Publication date: November 17, 2022
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Hyeonyoul Lee, Minju Kim, Daewook Kim, Min Kim, Jangjoon Park, Kyung-Ran Kim, Hyelin Ji
  • Composition for treating pain
    Patent number: 11433145
    Abstract: The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: September 6, 2022
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Hyeonyoul Lee, Minju Kim, Daewook Kim, Min Kim, Jangjoon Park
  • Method for delivery of biological molecule to nervous tissue
    Patent number: 10898590
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: January 26, 2021
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Yejin Kwon, Hyeonyoul Lee, Minju Kim, Daewook Kim, Jangjoon Park, Yeomoon Sim
  • COMPOSITION FOR ALLEVIATING OR TREATING PAIN
    Publication number: 20190255152
    Abstract: The present invention relates to a composition for alleviating or treating pain. A pharmaceutical composition of the present invention contains two or more selected from the group consisting of GAD, IL-10, and a gene encoding GDNF. The pharmaceutical composition of the present invention exhibits an excellent analgesic effect at a dosage lower than that of individual administration since genes are coadministered, and thus conventional side effects and toxicity can be reduced. Therefore, the pharmaceutical composition of the present invention can be useful in alleviating or treating pain.
    Type: Application
    Filed: October 31, 2017
    Publication date: August 22, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Yejin KWON, Minjung KIM, Minju KIM, Daewook KIM, Jangjoon PARK, Jongho CHO, Soondong LEE, Joonsung KIM, Yeomoon SIM
  • METHOD FOR DELIVERY OF BIOLOGICAL MOLECULE TO NERVOUS TISSUE
    Publication number: 20190099504
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 4, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Kyoungbaek CHOI, Minjung KIM, Yejin KWON, Hyeonyoul LEE, Minju KIM, Daewook KIM, Jangjoon PARK, Yeomoon SIM
  • COMPOSITION FOR TREATING PAIN
    Publication number: 20180250421
    Abstract: The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.
    Type: Application
    Filed: September 20, 2016
    Publication date: September 6, 2018
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Kyoungbaek CHOI, Minjung KIM, Hyeonyoul LEE, Minju KIM, Daewook KIM, Min KIM, Jangjoon PARK